Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Baughman Michael JExec VP, CFO & CAO | Grant or award | A | — 13.8K sh | Nov 4, 2026 |
| 13 | Stiefel Justin BDirector, CEO & Treasurer | Tax withholding | F | $961 433 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Gordon William BDirector | Open-market sale · 10b5-1 plan | SELL | $97K 700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO | Open-market sale · 10b5-1 plan | SELL | $119K 380 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Raabe Kyle AndrewPresident, Home Power Gen. | Open-market sale · 10b5-1 plan | SELL | $81K 386 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Lanigan Mark W.Director | Grant or award | A | — 4,562 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Rubin ElaineDirector | Grant or award | A | $18K 40.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Wetherbee Robert SDirector | Grant or award | A | $23K 128 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Clark LauraDirector, CEO | Grant or award | A | — 4,333 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $49K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $50K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Linnane Robert13D Group Member | Tax withholding | F | $17K 608 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $31K 470 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $33K 80 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $49K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Derhacobian NarbehDirector | Option exercise | M | — 8,541 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Mitra SabyaschiGroup President | Grant or award | A | — 10.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | Open-market sale · 10b5-1 plan | SELL | $2,717 7 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Buch James R.Director | Grant or award | A | — 4,562 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Gordon William BDirector | Open-market sale · 10b5-1 plan | SELL | $190K 1,374 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Stiefel Justin BDirector, CEO & Treasurer | Option exercise | M | — 208 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Angel Stephen FDirector, President & CEO | Grant or award | A | $9,034 175 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Hooks Michael K.Director | Grant or award | A | — 4,562 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO | Open-market sale · 10b5-1 plan | SELL | $202K 640 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO | Open-market sale · 10b5-1 plan | SELL | $201K 640 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Sine Jared F.Chief Strategy & Legal Officer | Open-market sale · 10b5-1 plan | SELL | $118K 1,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Utterback Cynthia ADirector | Grant or award | A | — 1,232 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $3,494 9 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO | Open-market sale · 10b5-1 plan | SELL | $63K 200 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Chemodurow TanyaDirector | Grant or award | A | — 1,232 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Murphy Peter EDirector | Grant or award | A | — 4,562 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $35K 662 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Tang MichaelSr VP, Secy & Chf Leg Ofc | Grant or award | A | — 6,227 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Palatnik Kevin S.Director | Option exercise | M | — 8,541 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Train Michael H.SVP & Chief Sustain Officer | Grant or award | A | — 20.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Printer HoshiDirector | Option exercise | M | — 8,541 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Swartz AllisonEVP, GC | Grant or award | A | — 8,160 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Ramnath VidyaSenior VP &CMO | Grant or award | A | — 2,767 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Chapman Steven LeonardDirector, CEO AND PRESIDENT | Open-market sale · 10b5-1 plan | SELL | $8,146 21 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Chandra SunilDirector | Grant or award | A | $32K 550 sh | Nov 4, 2026 traded Nov 3, 2026 |